XTE is close to realising the value that has always been there after a strong accumulation phase over the last few months. Stock has really tightened up as the fundamental story becomes more compelling.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025